Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human StudyNaresh Bumma,Joshua Richter,Jason Brayer,Jeffrey A. Zonder,Madhav Dhodapkar,Mansi R. Shah,James E. Hoffman,Raya Mawad,Joseph J. Maly,Suzanne Lentzsch,Attaya Suvannasankha,Pourab Roy, Jyotirmoy Dey,Dhruti Chokshi,Anita Boyapati, Jenn Visich,Yariv Houvras,Karen Rodriguez Lorenc,Glenn S. Kroog,Sundar JagannathBlood（2022）引用 8|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
